Standardized Neurologic Evaluations of 128 Patients With Wegener Granulomatosis
Top Cited Papers
Open Access
- 1 August 2001
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 58 (8) , 1215-1221
- https://doi.org/10.1001/archneur.58.8.1215
Abstract
WEGENER granulomatosis (WG) has the highest incidence of all antineutrophil cytoplasmic antibody (ANCA)–associated systemic vasculitides and is characterized by necrotizing small vessel vasculitis and granulomatous lesions.1 The reported frequency of neurologic involvement in WG ranges from 22% to 54%2-5 and clinical manifestations are variable. Drachman4 had already recognized the following 3 pathophysiologically relevant processes: (1) contiguous spread of granulomatous disease from the ear, nose, and throat tract into the brain and cranial nerves; (2) formation of granuloma primarily in the nervous system; and (3) vasculitis affecting the central nervous system (CNS) and/or the peripheral nervous system.Keywords
This publication has 8 references indexed in Scilit:
- Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitisKidney International, 1998
- Vasculitis confined to peripheral nervesBrain, 1996
- Conduction block in neuropathies with necrotizing vasculitisMuscle & Nerve, 1990
- Peripheral neuropathy in systemic vasculitisNeurology, 1986
- The clinical spectrum of necrotizing angiopathy of the peripheral nervous systemAnnals of Neurology, 1985
- Neurological complications of vasculitisAnnals of Neurology, 1983
- Neurologic manifestations of systemic vasculitis: a retrospective and prospective study of the clinicopathologic features and responses to therapy in 25 patientsThe American Journal of Medicine, 1981
- Non-healing Granuloma and the Nervous SystemQJM: An International Journal of Medicine, 1975